104 related articles for article (PubMed ID: 6296172)
1. Antibodies to poliovirus detected by immunoradiometric assay with a monoclonal antibody.
Spitz M; Fossati CA; Schild GC; Spitz L; Brasher M
J Virol Methods; 1982 Oct; 5(2):101-11. PubMed ID: 6296172
[TBL] [Abstract][Full Text] [Related]
2. Poliovirus neutralization and the percentage law. Brief report.
Brioen P; Boeyé A
Arch Virol; 1985; 83(1-2):105-11. PubMed ID: 2982345
[TBL] [Abstract][Full Text] [Related]
3. Production of monoclonal and monospecific antibodies against non-capsid proteins of poliovirus.
Pasamontes L; Egger D; Bienz K
J Gen Virol; 1986 Nov; 67 ( Pt 11)():2415-22. PubMed ID: 2431100
[TBL] [Abstract][Full Text] [Related]
4. Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.
Taniguchi K; Urasawa S
Arch Virol; 1987; 92(1-2):27-40. PubMed ID: 2432854
[TBL] [Abstract][Full Text] [Related]
5. A neutralizing monoclonal antibody against poliovirus and its reaction with related antigens.
Icenogle J; Gilbert SF; Grieves J; Anderegg J; Rueckert R
Virology; 1981 Nov; 115(1):211-5. PubMed ID: 6270899
[No Abstract] [Full Text] [Related]
6. A hybridoma cell line secreting antibody to poliovirus type 3 D-antigen: detection in virus harvest of two D-antigen populations.
Ferguson M; Schild GC; Minor PD; Yates PJ; Spitz M
J Gen Virol; 1981 Jun; 54(Pt 2):437-42. PubMed ID: 6270261
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies reactive with different sites of N and H antigenic particles of poliovirus.
Taniguchi K; Urasawa S; Urasawa T
J Gen Virol; 1983 Dec; 64 ( Pt 12)():2803-8. PubMed ID: 6198442
[TBL] [Abstract][Full Text] [Related]
8. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
[TBL] [Abstract][Full Text] [Related]
9. Antigenic analysis of poliovirus type 3 using monoclonal antibodies.
Ferguson M; Minor PD; Magrath DI; Schild GC
Dev Biol Stand; 1984; 57():151-5. PubMed ID: 6098495
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies reveal in blocking reactions the antigenicity and antibody response of poliovirus.
Uhlig H; Rutter G; Dernick R
Dev Biol Stand; 1984; 57():187-91. PubMed ID: 6084610
[TBL] [Abstract][Full Text] [Related]
11. Characterization of human monoclonal antibodies that neutralize multiple poliovirus serotypes.
Puligedda RD; Kouiavskaia D; Al-Saleem FH; Kattala CD; Nabi U; Yaqoob H; Bhagavathula VS; Sharma R; Chumakov K; Dessain SK
Vaccine; 2017 Oct; 35(41):5455-5462. PubMed ID: 28343771
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies to polioviruses. Production of specific monoclonal antibodies to the Sabin vaccine strains.
Osterhaus AD; van Wezel AL; van Steenis B; Drost GA; Hazendonk TG
Intervirology; 1981; 16(4):218-24. PubMed ID: 6177658
[TBL] [Abstract][Full Text] [Related]
13. Induction of neutralizing antibody in mice against poliovirus type II with monoclonal anti-idiotypic antibody.
Uytdehaag FG; Osterhaus AD
J Immunol; 1985 Feb; 134(2):1225-9. PubMed ID: 2981264
[TBL] [Abstract][Full Text] [Related]
14. Antigenic sites of poliovirus type 3 eliciting IgA monoclonal antibodies in orally immunized mice.
Buttinelli G; Ruggeri FM; Marturano J; Novello F; Donati V; Fiore L
Virology; 2001 Mar; 281(2):265-71. PubMed ID: 11277698
[TBL] [Abstract][Full Text] [Related]
15. Reactivity of anti-peptide and anti-poliovirus type 3 monoclonal antibodies with synthetic peptides.
Ferguson M; Reed SE; Minor PD
J Gen Virol; 1986 Nov; 67 ( Pt 11)():2527-31. PubMed ID: 2431104
[TBL] [Abstract][Full Text] [Related]
16. Evidence for several unrelated neutralization epitopes of poliovirus, type 1, strain Mahoney, provided by neutralization tests and quantitative enzyme-linked immunosorbent assay (ELISA).
Uhlig H; Rutter G; Dernick R
J Gen Virol; 1983 Dec; 64 ( Pt 12)():2809-12. PubMed ID: 6198443
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of poliovirus by polyclonal antibodies requires binding of a single IgG molecule per virion.
Wetz K; Willingmann P; Zeichhardt H; Habermehl KO
Arch Virol; 1986; 91(3-4):207-20. PubMed ID: 3022677
[TBL] [Abstract][Full Text] [Related]
18. Hybridoma antibodies to poliovirus N and H antigen.
Brioen P; Sijens RJ; Vrijsen R; Rombaut B; Thomas AA; Jackers A; Boeyé A
Arch Virol; 1982; 74(4):325-30. PubMed ID: 6187316
[No Abstract] [Full Text] [Related]
19. Method for the simultaneous assay of the different poliovirus types using surface plasmon resonance technology.
Manin C; Naville S; Gueugnon M; Dupuy M; Bravo de Alba Y; Adam O
Vaccine; 2013 Feb; 31(7):1034-9. PubMed ID: 23277095
[TBL] [Abstract][Full Text] [Related]
20. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
